Genefron is specializing in genomic expression based personal diagnostics in viral and autoimmune diseases. We are using gene expression signatures derived from big data analysis, machine learning algorithm and cell biology knowledge. Genefron has already developed its first 3 personal diagnostic kits (PDK) – all CE marked and with Israeli ministry of health approval: IFR 300 In RA (Rheumatoid Arthritis) patients – a PDK predicting treatment outcome of the ‘Anti TNF’ drug family; - Sell through Meuhedet HMO IFR 100 In MS (Multiple Sclerosis) patients – a PDK predicting treatment outcome of the ‘Interferon β’ drug family IFR 200 – predicting CMV (cytomegalovirus) transmission to fetus in pregnant women - Can be reimburse by Clalit Mashlim
View Top Employees from Genefron Ltd.Website | https://www.genefron.com/ |
Revenue | $2 million |
Employees | 3 (0 on RocketReach) |
Founded | 2011 |
Phone | +972 52-595-5554 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Health Diagnostics, Business Services, Health Care |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular Genefron Ltd. employee's phone or email?
The Genefron Ltd. annual revenue was $2 million in 2024.
Genefron Ltd. is based in Jerusalem, Jerusalem.
The NAICS codes for Genefron Ltd. are [54, 5417, 54171, 541713, 541].
The SIC codes for Genefron Ltd. are [87, 873].